Single Nucleotide Polymorphism (SNP) is usually a mutation found at a specific locus or a single base pair mutation containing two alleles. SNPs aid in understanding the correlations among genotype and behavior indicated by all living organisms. SNP genotyping is the measurement of genetic variations that commonly occur in individuals. Unlike conventional time consuming, expensive and labor extensive detection technology, SNP technology is highly efficient, relatively inexpensive and automated.

Portland, OR -- (SBWire) -- 09/08/2017 --Analysis of SNPs is widely utilized in different disciplines of genetics and related studies, commonly associated with studying genetic determinants of many complex diseases. SNP technologies are extensively utilized for detection and are beneficial in the etiology of several human diseases such as cancer, cardiovascular, Alzheimers, Asthma and others.

Acess full summary of the report: https://www.alliedmarketresearch.com/single-nucleotide-polymorphism-genotyping-market

In addition, SNPs are an essential markers in various human ailments and are intensely employed in pharmacogenomics to customize personalized medicine in a better way. Therefore, rising applications of SNPs in several Life Sciences & Biotechnology aspects are driving the Single Nucleotide Polymorphism (SNP) genotyping market. Furthermore, emerging technologies of SNP genotyping in Life Sciences field such as Agricultural biotechnology, diagnostic research, pharmaceuticals, pharmacogenomics and animal & livestock breeding is expected to boost the market growth in future. Other key factors driving the market are rising prevalence of diabetes, cardiovascular diseases and cancer. However, insufficient reimbursement policies limit the growth of SNPs genotyping market.

The Global Single Nucleotide Polymorphism (SNP) genotyping market is segmented on the basis of technologies, applications and geography. Based on the technologies, the market is segmented into SNP Genechips and Microarrays, TaqMan Assay (Allelle-Specific Hybridization), SNP, genotyping based upon Pyrosequencing, SN Plex based upon Applied Biosystems, Sequenom Masarray MALDI-TOF, RFLP (Restricted Fragment Length Polymorphism), SSCP (Single-Strand Conformation Polymorphism), ARMS (Amplication Refractory Mutation System) and Other SNP genotyping technologies. There are several application of SNPs that include Animal genetics, Plant improvement, Diagnostic research, Aquaculture, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology, Animal Livestock and breeding and Other SNP applications. Amongst all the applications, pharmacogenomics and diagnostics are the most attractive application in this market. Geographically, the report is segmented across four regions namely North America, Europe, Asia Pacific, and LAMEA. North America is the dominating region in Single Nucleotide Polymorphism (SNP) genotyping market due to growing commercial research in personalized medicines, animal breeding and others. In addition, Asia Pacific is the fastest growing market due to the rising demand of SNP genotyping in emerging economies such as China and India across different fields, which largely propells the market growth. Key strategies adopted by major players in this market include product launches, collaborations and agreements. Recently, on April 13, 2015, Affymetrix Inc., collaborated with MTI Ltd. for personal genomics and genetic research services in Japan to expand their business in healthcare. Companies profiled in this report include Beckman Coulter, Bio-Rad Laboratories, GE Healthcare, Affymetrix Inc., Sequenom, Inc., Roche Holding AG, Qiagen, Fluidigm Corporation, Agilent Technologies, Thermo Fisher Scientific Inc., and few others

Get PDF Brochure of this report Study: https://www.alliedmarketresearch.com/request-toc-and-sample/1464

Early buyers will receive 20% customization on this report